Vera therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Brisbane, calif., feb. 13, 2025 (globe newswire) -- vera therapeutics, inc. (nasdaq: vera) today announced that on february 8, 2025, the compensation committee granted inducement awards consisting of a non-qualified stock option to purchase 157,750 shares of class a common stock and restricted stock units (rsus) for 78,875 shares of class a common stock to seventeen (17) new employees under the inducement plan.
NDAQ Ratings Summary
NDAQ Quant Ranking